▲ BUY
5
/ 10
Conviction
$ Value
$21K
Shares
5,076
Price
$4
Filed
Jun 27
▶ Why this score? (5/10)
- ✓ Open market buy (+3)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Buehler Kevin
Title
—
CIK
0001792722
Roles
Director
Transaction Details
Transaction Date
2025-06-25
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
28,137
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.16 to $4.18. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
Filing Info
Buehler Kevin's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-06-25 | DTIL | ▲ | $21K ★ |
| 2025-06-03 | DTIL | A | $0 |
| 2025-05-27 | DTIL | M | — |
| 2025-05-27 | DTIL | M | $0 |
Other Insiders at DTIL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Kelly John Alexander
Chief Financial Officer
|
— | $31K | 2026-02-18 |
|
SMITH J. JEFFERSON
Chief Research Officer
|
— | $19K | 2026-02-18 |
|
Scimeca Dario
General Counsel and Secretary
|
— | $19K | 2026-02-18 |
|
Amoroso Michael
President and CEO
|
— | $79K | 2026-02-18 |